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ABSTRACT
Metallodrugs provide important first-line treatment
against various forms of human cancer. To overcome
chemotherapeutic resistance and widen treatment
possibilities, new agents with improved or alterna-
tive modes of action are highly sought after. Here,
we present a click chemistry strategy for develop-
ing DNA damaging metallodrugs. The approach in-
volves the development of a series of polyamine
ligands where three primary, secondary or tertiary
alkyne-amines were selected and ‘clicked’ using the
copper-catalysed azide-alkyne cycloaddition reac-
tion to a 1,3,5-azide mesitylene core to produce a
family of compounds we call the ‘Tri-Click’ (TC) se-
ries. From the isolated library, one dominant ligand
(TC1) emerged as a high-affinity copper(II) binding
agent with potent DNA recognition and damaging
properties. Using a range of in vitro biophysical and
molecular techniques––including free radical scav-
engers, spin trapping antioxidants and base excision
repair (BER) enzymes––the oxidative DNA damag-
ing mechanism of copper-bound TC1 was elucidated.
This activity was then compared to intracellular re-
sults obtained from peripheral blood mononuclear
cells exposed to Cu(II)–TC1 where use of BER en-
zymes and fluorescently modified dNTPs enabled the
characterisation and quantification of genomic DNA
lesions produced by the complex. The approach can
serve as a new avenue for the design of DNA damag-
ing agents with unique activity profiles.
INTRODUCTION
Nucleic acids are ubiquitous biomolecules chiefly respon-
sible for mediating faithful cellular replication and trans-
lation in nearly all forms of cellular life. Both DNA and
RNA are therefore subjected to intensive drug discovery ef-
forts so that cancer, monogenetic, and pathogenic diseases
can be effectively treated (1). Since double helical DNA en-
codes genetic information, it serves as a primary target for
small molecule binding agents (2). These interactions typ-
ically involve molecular recognition such as the curvature
of the major or minor groove, the negatively charged phos-
phate backbone, or the space between specific base pairs
(steps) required for intercalation. Binding at the molecular
level broadly falls into two main categories: covalent and
non-covalent. Covalent binders directly coordinate nucleic
acids distorting their shape, structure and function and are
often used as first line treatments against cancer; the inter-
action is considered permanent as it can be removed only
by DNA excision repair enzymes. Non-covalent binders in-
teract transiently but in doing so also distort shape and
function as the primary structure reorganises to accom-
modate the ligand (3,4). Characterising purely covalent or
non-covalent interactions can be difficult as many cova-
lent binders must firstly interact with DNA preassociativ-
ity using non-covalent interactions (kinetically fast) prior to
bond formation (kinetically slow). A specific example of this
effect can be traced in the interaction of the anticancer drug
cisplatin (cis-[Pt(NH3)2Cl2]) where non-covalent am(m)ine-
phosphate interactions provide initial anchoring of the
molecule prior to Pt(II) crosslinking adjacent purine bases
(5). Conversely, several important classes of DNA dam-
aging drugs including metallobleomycin and neocarzino-
statin are potent non-covalent binding agents. But in
their subsequent oxidative DNA damaging phases they
activate C–H deoxyribose bonds producing double stand
breaks that covalently modify the underlying nucleic acid
structure (6).
Several clues for developing new bioactive agents
have been taken from naturally occurring molecules that
recognise DNA. For instance, antibiotic groove binders,
such as netropsin and distamycin A contain heterocyclic
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pyrrole rings that contort into a crescent shape that mim-
ics the curvature of the A–T rich minor groove (7–9). Al-
ternatively, heterocycles of extended planarity can -stack
between adjacent base pairs. The naturally occurring gly-
copeptide bleomycin contains one such moiety––a bithia-
zole group which intercalates duplex DNA via the minor
groove and which is proximate to a polyamine chelator that
coordinates first row transition metals including copper and
iron (10). An activated metallobleomycin intermediate (e.g.
bleomycin-Fe(III)-OOH) then promotes H-atom abstrac-
tion from deoxyribose to form single strand breaks (SSBs),
and more difficult to repair double strand breaks (DSBs)
central to its anticancer properties (11). Similar to the bithi-
azole moiety of bleomycin, a thiazole/5-hydroxyoxazole tail
was recently proposed as the intercalating unit of macro-
cyclic colibactin––a human gut bacterial genotoxin which
induces DNA double-strand breaks via copper-mediated
oxidative cleavage (12) but which may ostensibly alkylate
DNA due to the presence of an electrophilic cyclopropane
group (13–15).
Copper complexes have recently emerged as attractive
chemotypes for treating human cancer. Part of this interest
stems from their redox properties, wide structural variabil-
ity, and the bioavailability of copper. In recent years sev-
eral promising preclinical Cu(II) complexes, including the
naturally occurring polypeptide ATCUN (amino terminal
Cu(II) and Ni(II) binding) motif, (16) were applied as DNA
damaging pro-oxidants within human cancer cells. Start-
ing with the Cu(II) bis-1,10-phenanthroline chemotype
(17)––recognised as the first artificial chemical nuclease––it
was shown how introducing designer phenazine ligands
with extended planarity enhances DNA binding and cleav-
age activity (18). More recently, tri- and dipodal caging lig-
ands such as tris-(2-pyridylmethyl)amine (TMPA) (19) and
di-(2-pycolylamine) (DPA) (20) were developed to improve
solution stability and allow coordination of designer inter-
calating groups. Several of these caging complexes displayed
encouraging activity against recalcitrant human cancers in-
cluding neuroblastoma and pancreatic ductal adenocarci-
noma (21). Despite this promise, some of the most interest-
ing preclinical agents have emerged from polynuclear metal
complex design. Polynuclear systems can mediate DNA
damage in the absence of exogenous reductant––a property
referred to as ‘self-activation’––with selective interactions
such as discrimination between AT/AT and TA/TA base
pairs (22) along with discrete binding in the major groove,
(23) at helix-coil junctions, (24–26) or at three-way junctions
(27) are possible through careful design. The use of polynu-
clear complexes therefore provides cooperative interactions
at the drug–DNA interface that are not possible to achieve
with simple mononuclear agents.
We recently reported an unusual C3-symmetric opioid
scaffold with nucleic acid condensation properties and in-
vestigated its non-viral transfection properties (28). The
preparation of this scaffold relied on coupling three mor-
phine, heterocodeine, oripavine or codeine (29) molecules
to a central mesitylene core. Protonation of a tertiary amine
(present in the piperidine ring of each opioid) then pro-
vided an overall 3+ cationic charge central to DNA charge
neutralisation and condensation. In this work, we ques-
tion if a similar C3-symmetric approach could be applied to
develop therapeutically active DNA oxidants, and if click
chemistry could provide a modular strategy for the devel-
opment of such agents. Although click chemistry has an
extensive range of applications in the field of nucleic acid
click chemistry, (30–33), it has not yet been widely em-
ployed to construct DNA binding metallodrugs (34–36).
An exception is polyamine G-quadruplex stabilising com-
pounds where multiple triazole rings were found not only
to anchor specific, protonatable, amine side chains but also
played crucial roles in -stacking interactions with terminal
G-quartets (34). To facilitate the current strategy, we pre-
pared a 1,3,5-azide mesitylene core and applied copper(I)-
catalysed azide-alkyne cycloaddition (CuAAC) click chem-
istry using primary, secondary and tertiary alkyne-amines
to produce a library we call the ‘Tri-Click’ (TC) series. TC
compounds were then investigated for their ability to co-
ordinate first row transition metals with one ligand (TC1)
emerging as a high-affinity copper(II) binding agent with
potent DNA recognition and damaging properties.
MATERIALS AND METHODS
General remarks
Chemicals and reagents were sourced from Sigma-Aldrich
and Tokyo Chemical Industry (TCI) and were used with-
out any further purification. HPLC grade chloroform,
methanol, and acetonitrile were used without further pu-
rification. All other solvents were used as supplied. De-
tailed synthetic schemes are shown in Supplementary Sec-
tion S-1. All novel compounds were characterised by melt-
ing point (MP) (when appropriate), nuclear magnetic res-
onance (NMR) spectroscopy, attenuated total reflectance
(ATR) Fourier transform infrared (FTIR) spectroscopy,
and electron spray ionisation mass spectrometry (ESI-MS).
Thin layer chromatography was performed on Fluka Silica
gel (60 F254) coated on aluminium plates and visualised
using UV light. Davisil 60 Å silica gel was used for col-
umn chromatography. 1H and 13C NMR spectra were ob-
tained on a Bruker AC 400 MHz and 600 MHz NMR spec-
trometer (see supplementary section S-4). FT-IR spectra
were collected on Perkin Elmer Spectrum Two spectrome-
ter. Electrospray ionisation mass spectra were recorded us-
ing a Thermo Fisher Exactive Orbitrap mass spectrometer
coupled to an Advion TriVersa Nanomate injection system
with samples prepared in 100% HPLC-grade acetonitrile or
methanol. Accurate mass spectrometry was conducted on
a MaXis HD quadrupole electrospray time-of-flight (ESI-
QTOF) mass spectrometer (Bruker Daltonik GmbH, Bre-
men, Germany), using a glass syringe (Hamilton) and sy-
ringe pump (KD Scientific, Model 781100) for infusions at
a flow rate of 3 l/min.
Caution! Sodium azide is acutely toxic and is an explosion
hazard. Refer to organic azide stability prior to the prepara-
tion of any azido compounds. The total number of nitrogen
atoms in a final organic azide should not exceed that of car-
bon. Organic azides with C/N ratio of <1 should never be
isolated. It may be synthesized if the azide is a transient in-
termediate species and the limiting reagent in the reaction
mixture and is limited to a maximum quantity of 1 g. Each
azido compound should be individually evaluated.
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GenElute-Mammalian Genomic DNA Miniprep Kits,
tiron, D-mannitol, sodium pyruvate, APTES, ATMS, -
mercaptoethanol, L-histidine, calf-thymus (ctDNA, Ultra-
Pure 15633019) were purchased from Invitrogen while,
poly[d(A-T)2)] (P0883) and poly[d(G-C)2] (P9389) were
purchased from Sigma-Aldrich. CutSmart buffers, pUC19
plasmid (N3041) and repair enzymes––Fpg (M0240S),
Endo III (M0268S), Endo IV (M0304S), Endo V (M0305S),
hAAG (M0313S) and APE1 (M0282S)––were purchased
from New England Biolabs. Aminoallyl-dUTP-ATTO-
647N and YOYO-1 were purchased from Jena Bioscience
and Invitrogen, respectively.
The pH was monitored by a Mettler Toledo InLab Ex-
pert Pro-ISM pH probe. DNA binding analysis was con-
ducted on a Bio-Tek, Synergy HT fluorescent microplate
reader with Gen5 software. UV-visible spectrometry stud-
ies were carried out on a Shimadzu UV-2600. AFM images
where captured on Bruker Dimension Icon AFM equipped
with super sharp silicon cantilevers (SSS-NCHR, Windsor
Scientific Ltd). Zeiss Observer.Z1 equipped with an Andor




was carried out as per literature with slight modifications
(37). To a solution of 2,4,6-tris-(bromomethyl)-mesitylene
(1.025 g, 2.56 mmol) in DMF (25 ml), sodium azide (1.00
g, 15.38 mmol) was added in portions over ice over a period
of 20 min. (Caution! Sodium azide is acutely toxic and is
an explosion hazard. Refer to organic azide stability prior
to the preparation of any azido compounds). The reaction
was stirred on ice for 1 h prior to stirring at rt for 23 h. The
reaction was quenched with 8 ml of H2O, and extracted
with EtOAc (3 × 20 ml). The combined organic phase
was washed with H2O (5 × 5 ml) and the organic layer
dried over MgSO4, filtered and solvents removed by rotary
evaporation. The sample was recrystallized from a solvent
system of hex:EtOAc (5:1) to afford the triazide (0.677 g,
2.37 mmol, 93%) as a white crystalline solid. 1H NMR (600
MHz, CDCl3) : 4.50 (s, 6H), 2.46 (s, 9H).13C NMR (151
MHz, CDCl3) : 138.15, 130.88, 77.27, 77.06, 76.85, 48.94,
16.50. 1H and 13C NMR were in agreement with literature
data (37). IR (ATR, cm–1): 2901, 2085, 1678, 1572, 1449,
1232, 1072, 859, 698, 640, 552.
3-Ethynyl-N,N-dimethylaniline (1). Product was prepared
according to literature procedures with slight modifications
(38). To a solution of 3-ethynylaniline (1.034 g, 8.83 mmol)
and caesium carbonate (8.306 g, 25.5 mmol) in dry DMF
(50 ml) under nitrogen, methyl iodide was added drop wise
over 15 min (1.7 ml, 26.0 mmol). The reaction was heated
to 40◦C for 24 h and was monitored by TLC (Hex:EtOAc).
From the complete conversion by TLC, the reaction was
cooled and diluted with H2O (100 ml) and extracted with
EtOAc (3 × 30 ml). The organic layers were combined and
washed with H2O (3 × 10 ml) and finally with brine solu-
tion. The organic layer was dried over MgSO4 and reduced
to dryness. Product was purified by column chromatogra-
phy (SiO2, Hex:EtOAc, 9:1) as a yellow liquid (383 mg, 2.64
mmol, 30%).1H NMR (400 MHz, CDCl3) : 7.22–7.16 (m,
1H), 6.90–6.84 (m, 2H), 6.74 (ddd, J = 8.4, 2.6, 1.0 Hz, 1H),
3.03 (s, 1H), 2.95 (s, 6H). The 1H NMR spectrum agreed
with literature data (39).
4-Ethynyl-N,N-dimethylaniline (2). Product was prepared
according to literature procedures with slight modifications
(38). To a solution of 4-ethynylaniline (1.003 g, 8.56 mmol)
and cesium carbonate (8.345 g, 25.6 mmol) in dry DMF
(50 ml) under nitrogen, methyl iodide was added drop wise
over 15 min (1.6 ml, 26.0 mmol). The reaction was heated
to 40◦C for 24 h and monitored by TLC (Hex:EtOAc). The
reaction was cooled and diluted with H2O (100 ml) and ex-
tracted with EtOAc (3 × 30 ml). The organic layers were
combined and washed with H2O (3 × 10 ml) and finally with
brine solution. The organic layer was dried over MgSO4 and
reduced to dryness. Product was purified by column chro-
matography (SiO2, Hex:EtOAc, 9:1) as a colourless liquid
(383 mg, 2.64 mmol, 31%). 1H NMR (400 MHz, CDCl3)
: 7.39 (dt, 2H), 6.65 (dt, 2H), 3.00 (s, 7H). The 1H NMR
spectrum was in agreement with literature data (38).
N-Boc-3-ethynylaniline (3). The compound was prepared
according to reported methods (40). To a solution of 3-
ethynylaniline (5.040 g, 43.02 mmol) in dry THF (80 ml),
di-tert-butyl-dicarbonate (10.112 g, 46.33 mmol) in THF
(10 ml) was added dropwise. Reaction was refluxed for 18
h and monitored by TLC. Solvent was reduced under pres-
sure and the resulting material was purified by column chro-
matography (Hex:EtOAc) to yield the product as a colour-
less liquid (8.786 g, 40.44 mmol, 94% yield). 1H NMR (600
MHz, CDCl3) : 7.37 (d, J = 7.3 Hz, 1H), 7.24 (t, J = 7.8
Hz, 1H), 7.17 (dt, J = 7.6, 1.3 Hz, 1H), 6.58 (s, 1H), 3.06
(s, 1H), 1.53 (s, 9H). 1H NMR spectrum was in agreement
with literature data (41).
Boc-3-ethynyl-N-methylaniline (4). The target ligand was
prepared by previously reported methods with slight mod-
ifications (42). Sodium hydride (3 eq, 14.8 mmol) was pre-
pared in the reaction vessel under nitrogen flux and washed
with dry hexane, suspended in dry DMF (40 ml) over ice.
A solution of boc-3-ethynylaniline (1.038 g, 4.93 mmol) in
DMF (10 ml) was added slowly over 30 min to the reac-
tion under a nitrogen atmosphere and the resulting solution
was allowed to stir at rt for 2 h. Methyl iodide (1.54 ml, 5
eq, 24.7 mmol) was added to the reaction slowly over 5 min
and reaction left stirring for 4 h. The reaction was quenched
slowly with H2O at 0◦C. The solution was diluted with H2O
(50 ml) and extracted with EtOAc (4 × 30 ml). The organic
layers were combined and further washed with H2O (5 × 10
ml) and finally with brine. The organic layer was dried over
MgSO4, filtered and solvents removed by rotary evapora-
tion. The crude product was purified by column chromatog-
raphy (SiO2, 9.5:0.5 Hex:EtOAc) as an off white solid (850
mg, 3.68 mmol, 75%). 1H NMR (400 MHz, CDCl3) : 7.38
(q, J = 1.4 Hz, 1H), 7.31–7.26 (m, 3H), 3.27 (s, 3H), 3.09 (s,
1H), 1.47 (s, 9H). The 1H NMR spectrum was in agreement
with literature data (42).
Boc-Click reactions
Tri-Click boc-3-ethynylaniline (5). To a solution of triazide
(0.285, 1.00 mmol) and DIPEA (0.174 ml, 1.00 mmol) in de-
gassed ACN (20 ml), CuBr (0.144 g, 1.00 mmol) was added
slowly under nitrogen atmosphere. The solution was stirred
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for 15 min and boc-3-ethynylaniline (3, 0.679 g, 3.13 mmol)
was added dropwise as a solution in ACN (5 ml) to the reac-
tion. The reaction was refluxed for 50◦C for 48 h, until the
complete conversion was observed by TLC. The reaction
was allowed to cool and ACN removed by reduced pressure.
The resulting crude material was suspended in 0.1 M EDTA
solution (pH 8) and heated to reflux for 1 h. The solution
was allowed to cool and extracted with DCM (3 × 50 ml).
The organic layers were combined and washed with H2O
(3 × 30 ml) and brine. The organic solution was dried over
MgSO4 and reduced to dryness. The crude product was col-
umn purified (SiO4 DCM:MeOH, 9:1) resulting in the ti-
tle product as cream solid (505 mg, 0.538 mmol, 54%). 1H
NMR (400 MHz, CDCl3) : 7.77 (s, 3H), 7.57 (s, 3H), 7.51
(dd, J = 7.6, 1.4 Hz, 3H), 7.41 – 7.37 (m, 3H), 7.31 (t, J = 7.9
Hz, 3H), 6.80 (s, 3H), 5.74 (s, 6H), 2.49 (s, 9H), 1.52 (s, 27H).
Amine deprotection detailed below.
Tri-Click boc-3-ethynyl-N-methylaniline (6). To a solu-
tion of triazide (0.286, 1.00 mmol) and DIPEA (0.174 ml,
1.00 mmol) in degassed ACN (20 ml), CuBr (0.144 g, 1.00
mmol) was added slowly under nitrogen atmosphere. The
solution was stirred for 15 minutes and boc-3-ethynyl-N-
methylaniline (4, 0.718 g, 3.11 mmol) was added dropwise
as a solution in ACN (5 ml) to the reaction. The reaction
was refluxed for 18 h, until the complete conversion was
observed by TLC. The reaction was allowed to cool and
ACN removed by reduced pressure. The resulting crude was
suspended in 0.1 M EDTA solution (pH 8) and heated to
reflux for 1 h. The solution was allowed to cool and ex-
tracted with DCM (3 × 50 ml). The organic layers were
combined and washed with H2O (3 × 30 ml) and brine.
The organic solution was dried over MgSO4 and reduced
to dryness. The crude product was column purified (SiO4
DCM:MeOH, 9:1) and resulted in a white solid (866 mg,
0.88 mmol, 88%). 1H NMR (400 MHz, CDCl3) : 7.74 (t,
J = 1.9 Hz, 3H), 7.55 (d, J = 10.4 Hz, 6H), 7.35 (t, J = 7.8
Hz, 3H), 7.22 (ddd, J = 8.0, 2.3, 1.1 Hz, 3H), 5.75 (s, 6H),
3.29 (s, 9H), 2.54 (s, 9H), 1.47 (d, J = 2.8 Hz, 27H). Amine
deprotection procedure detailed below.
Tri-Click reactions
Tri-Click propargylamine (TC1). To a solution of triazide
(0.214 g, 0.75 mmol) in degassed t-BuOH:H2O (1:1, 6 ml),
propargylamine (147 l, 2.29 mmol) and Na-L-ascorbate
(5%, 0.15 mmol) was added and stirred under a nitrogen at-
mosphere for 15 min, prior to the addition of a solution of
CuSO4 (1%, 0.03 mmol) in t-BuOH:H2O (1:1, 2 ml) which
was added dropwise over 10 min. The reaction was stirred
at 25◦C for 18 h. The solvent was reduced to 3 ml under
a stream of nitrogen and cooled on ice. The resulting pre-
cipitate was collected by vacuum filtration and washed with
ice cold EDTA (0.1 M, 3 × 8 ml) and ice-cold diethyl ether
(3 × 10 ml). A yellow solid was recovered in good yield,
(284 mg, 0.63 mmol, 84%). MP: 119–120◦C. 1H NMR (600
MHz, D2O) : 7.66 (s, 3H), 5.64 (s, 6H), 3.77 (s, 6H), 2.21 (s,
9H). 13C NMR (151 MHz, D2O) : 148.32, 140.12, 130.00,
122.69, 49.03, 35.46, 15.51. IR (ATR, cm–1): 3124, 2982,
1666, 1603, 1442, 1381, 1328, 1215, 1120, 1046, 949, 802.
ESI-MS m/z: [M + H]+ Cald for C21H31N12+: 451.56; found
451.6.
Tri-Click N-methyl-propargylamine (TC2). To a solution
of triazide (0.430 g, 1.5 mmol) in degassed t-BuOH:H2O
(1:1, 8 ml), N-methyl-propargylamine (380 l, 4.52 mmol)
and Na-L-ascorbate (10%, 0.45 mmol) was added and
stirred under a nitrogen atmosphere for 15 min. A solu-
tion of CuSO4 (1%, 0.045 mmol) in t-BuOH:H2O (1:1, 2
ml) was added dropwise over 10 min and stirred at 25◦C for
18 h. The solvent was removed under reduced pressure and
the product was suspended in 0.1 M EDTA solution (pH
8) and extracted with DCM (3 × 50 ml). The organic lay-
ers were combined and washed with ice cold H2O (3 × 20
ml) and brine (3 × 30 ml). The organic solution was dried
over MgSO4 and solvent removed under reduced pressure.
A white solid was recovered (0.548 g, 1.13 mmol, 74%). MP:
197–199◦C. 1H NMR (600 MHz, CDCl3) : 7.24 (s, 3H),
5.63 (s, 6H), 3.82 (s, 6H), 2.44 (s, 9H), 2.38 (s, 9H).13C NMR
(151 MHz, CDCl3) : 146.83, 139.73, 130.66, 120.91, 48.88,
46.84, 36.16, 16.57. IR (ATR, cm–1): 3066, 2981, 1634, 1550,
1447, 1380, 1331, 1261, 1207, 1131, 1047, 811. ESI-MS m/z:
[M + H]+ Cald for C24H36N12+: 493.33; found 493.2.
Tri-Click N,N-dimethyl-propargylamine (TC3). To a so-
lution of triazide (0.286 1.00 mmol) and DIPEA (0.174
ml, 1.00 mmol) in degassed ACN (20 ml), CuBr (0.144 g,
1.00 mmol) was added slowly under nitrogen atmosphere.
The solution was stirred for 15 min and N,N-dimethyl-
propargylamine (0.340 ml, 3.16 mmol) was added dropwise
as a solution in ACN (5 ml) to the reaction. The reaction
was refluxed for 72 h, until the complete conversion was ob-
served by TLC. The reaction was allowed to cool and ACN
removed by reduced pressure. The resulting mixture was
suspended in 0.1 M EDTA solution (pH 8) and heated to re-
flux for 1 h. The solution was allowed to cool and extracted
with DCM (3 × 50 ml). The organic layers were combined
and washed with H2O (3 × 20 ml) and brine (3 × 30 ml).
The organic solution was dried over MgSO4 and solvent re-
moved under reduced pressure. The resulting product was
column purified (SiO4 DCM:MeOH, 9:1) and isolated as an
orange solid (338 mg, 0.63 mmol, 63%). MP: 227–229◦C.
1H NMR (600 MHz, (CD3)2SO) : 7.75 (s, 3H), 5.67 (s,
6H), 3.43 (s, 6H), 2.39 (s, 9H), 2.09 (s, 18H). 13C NMR (151
MHz, (CD3)2SO) : 144.10, 139.56, 131.42, 123.66, 54.02,
48.75, 45.04, 16.71. Anal. Cal. for C27H42N12: C, 60.65; H,
7.92; N, 31.43. %Found: C 59.34, H 7.72, N 30.45. IR (ATR,
cm–1): 3111, 3070, 2977, 2939, 2814, 2762, 1455, 1380, 1336,
1297, 1255, 1213, 1174, 1135, 1037, 1016, 840, 812, 798, 704.
ESI-MS m/z: [M]+ Cald for C27H42N12: 534.7; found 535.3.
Tri-Click 3-ethynylaniline (TC4). The procedure was
adapted from the literature (42). To a solution of Tri-Click
boc-3-ethynylaniline (5) (0.505 mg, 0.539 mmol) in DCM
(10 ml) TFA (0.615 l, 8 mmol) was added slowly over ice.
The solution was allowed to stir over ice and monitored by
TLC to ensure complete removal of Boc group. The sol-
vent and excess TFA were removed under a stream of nitro-
gen, residue was dissolved in HCl (aq) (1.0 M, 10 ml) and
washed with DCM (3 × 20 ml). DCM (20 ml) and water
(20 ml) was added to the aqueous fraction and the pH was
adjusted to 8 with NaOH (1 M) while stirring. The organic
fraction was collected, and the aqueous layer was extracted
with DCM (2 × 10 ml). The combined organic fractions
were dried (MgSO4), filtered and the solvent was removed
under reduced pressure. The resulting product was column
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purified (SiO4 DCM:MeOH, 9:1) to afford a white solid
(0.295 g, 0.464 mmol, 86%). MP: 228–230◦C. 1H NMR
(600 MHz, (CD3)2SO) : 8.24 (s, 3H), 7.12 (t, J = 2.0 Hz,
3H), 7.06 (t, J = 7.8 Hz, 3H), 6.97 (dt, J = 7.5, 1.2 Hz,
3H), 6.54 (ddd, J = 8.0, 2.4, 1.1 Hz, 3H), 5.74 (s, 6H), 3.35
(s br, 6H), 2.48 (s, 9H). 13C NMR (151 MHz, (CD3)2SO)
: 157.87, 157.66, 148.37, 146.77, 139.40, 131.11, 130.81,
129.27, 120.62, 113.88, 113.57, 110.82, 48.59, 16.42.IR
(ATR, cm–1): 3347, 1674, 1611, 1589, 1430, 1182, 1123,
1045, 836, 802, 782, 722, 691. ESI-MS m/z: [M + H]+ Cald
for C36H37N12+: 637.3; found 637.3.
Tri-Click 3-ethynyl-N-methylaniline (TC5). The removal
of the protecting group was carried as stated above. Briefly,
to a solution of Tri-Click boc-3-ethynyl-N-methylaniline (6)
(0.850 g, 0.87 mmol) in DCM (15 ml) TFA (1 ml, 13.05
mmol) was added slowly over ice. The solution was allowed
to stir over ice and monitored by TLC to ensure complete
removal of Boc group. No alterations were made to the
workup as detailed previously. The resulting product was
column purified (SiO4 DCM:MeOH, 9:1). Solvent was re-
moved under reduced pressure and foamed with THF to
afford an extremely hygroscopic white solid (0.366 g, 0.539
mmol, 62%). Product is stored under argon. 1H NMR (600
MHz, (CD3)2SO) : 8.31 (s, 3H), 7.17 – 7.13 (m, 6H), 7.08
(dt, J = 7.6, 1.3 Hz, 3H), 6.59 (ddd, J = 8.0, 2.4, 1.0 Hz,
3H), 5.75 (s, 6H), 2.73 (s, 9H), 2.49 (s, 9H). 13C NMR
(151 MHz, (CD3)2SO) : 146.81, 139.50, 131.32, 130.87,
129.40, 120.87, 119.79, 117.83, 115.86, 114.22, 113.89,
112.54, 109.16, 48.63, 30.42, 16.50, 1.17. IR (ATR, cm–1):
3112, 1670, 1435, 1177, 1123, 837, 7800, 722, 710, 599, 518.
ESI-MS m/z: [M + H]+ Cald for C39H43N12+: 679.4; found
679.4. Note: hygroscopic, requires storage under argon
Tri-Click 3-ethynyl-N,N-dimethylaniline (TC6). To a so-
lution of triazide (0.286, 1.00 mmol) and DIPEA (0.174
ml, 1.00 mmol) in degassed ACN (20 ml), CuBr (0.144 g,
1.00 mmol) was added slowly under nitrogen atmosphere.
The solution was stirred for 15 min and 3-ethynyl-N,N-
dimethylaniline (1, 0.450 g, 3.09 mmol) was added dropwise
as a solution in ACN (5 ml) to the reaction. The reaction
was heated to 50◦C under nitrogen for 24 h, until complete
conversion was observed by TLC. The reaction was allowed
to cool and ACN removed by reduced pressure. The result-
ing crude was suspended in 0.1 M EDTA solution (pH 8)
and heated to reflux for 1 h. The solution was allowed to
cool and extracted with DCM (3 × 50 ml). The organic
layers were combined and washed with H2O (3 × 30 ml)
and brine. The organic solution was dried over MgSO4 and
reduced to dryness. The crude product was column puri-
fied (SiO4 DCM:MeOH, 9:1) and isolated as beige powder
(399 mg, 0.52 mmol, 52%). MP: 259–260◦C. 1H NMR (600
MHz, CDCl3) : 7.46 (s, 3H), 7.29 (dd, J = 2.7, 1.5 Hz,
3H), 7.21 (t, J = 8.2 Hz, 3H), 6.95 (ddd, J = 7.5, 1.5, 0.9
Hz, 3H), 6.69 (ddd, J = 8.4, 2.7, 0.9 Hz, 3H), 5.71 (s, 6H),
2.98 (s, 18H), 2.51 (s, 9H). 13C NMR (151 MHz, CDCl3)
: 151.13, 148.74, 139.96, 131.00, 130.98, 129.58, 118.98,
114.19, 112.69, 109.75, 49.21, 40.78, 16.96. IR (ATR, cm–1):
1605, 1582, 1497, 1442, 1350, 1223, 1182, 1042, 986, 857,
780, 692, 461. Anal. Cal. for C42H48N12: C, 69.97; H,
6.71; N, 23.31. %Found: C, 69.30; H, 6.66; N, 22.70. ESI-
MS m/z: [M + H]+ Cald for C42H49N12+: 721.4; found
721.4.
Tri-Click 4-ethynyl-N,N-dimethylaniline (TC7). To a so-
lution of triazide (0.286, 1.00 mmol) and DIPEA (0.174
ml, 1.00 mmol) in degassed ACN (20 ml), CuBr (0.144 g,
1.00 mmol) was added slowly under nitrogen atmosphere.
The solution was stirred for 15 min and 4-ethynyl-N,N-
dimethylaniline (2, 0.454 g, 3.13 mmol) was added drop-
wise as a solution in ACN (5 ml). The reaction was re-
fluxed for 72 h, until the complete conversion was observed
by TLC. The reaction was allowed to cool and ACN re-
moved by reduced pressure. The resulting crude was sus-
pended in 0.1 M EDTA solution (pH 8) and heated to reflux
for 1 h. The solution was allowed to cool and extracted with
DCM (3 × 50 ml). The organic layers were combined and
washed with H2O (3 × 30 ml) and brine. The organic so-
lution was dried over MgSO4 and reduced to dryness. The
crude product was column purified (SiO4 DCM:MeOH,
9:1) and isolated as a cream solid (249 mg, 0.345 mmol,
35%). MP: 284–286◦C. 1H NMR (600 MHz, (CD3)2SO) :
8.09 (s, 3H), 7.63 (d, J = 8.8 Hz, 6H), 6.71 (d, J = 8.9 Hz,
6H), 5.73 (s, 6H), 2.91 (s, 18H), 2.47 (s, 9H).13C NMR (151
MHz, (CD3)2SO) : 150.41, 147.27, 139.75, 131.35, 126.58,
119.39, 119.02, 112.66, 49.00, 16.84. ATR-IR (cm–1): 2851,
1619,1559, 1443,1348, 1220, 1170, 1040, 947, 812, 695, 533.
ESI-MS m/z: [M + H]+ Cald for C42H49N12+: 721.4; found
721.4.
Investigation of the para-substituted 4-ethynylanilines
N-Boc-4-ethynylaniline (7). The compound was prepared
according to literature procedures (43,44). To a solution
of 4-ethynylaniline (5 mmol) in dry THF (20 ml), di-tert-
butyl dicarbonate (15 mmol) was added dropwise. Reaction
was refluxed under nitrogen for 18 h. Monitored by TLC
(Hex:EtOAc 9:1) until the complete conversion of prod-
uct was observed. The reaction was allowed to cool to rt
and solvent removed under reduced pressure. Crude yel-
low oil was subjected to column chromatography (SiO2,
Hex:EtOAc, 9.5:0.5–9:1) to yield the pure product as a
colourless liquid in high yield (0.98 g, 4.51 mmol, 90%
yield). 1H NMR (400 MHz, CDCl3) : 7.47–7.31 (m, 4H),
6.64 (s, 1H), 3.04 (s, 1H), 1.53 (s, 9H). The 1H NMR spectra
was in agreement with literature data (44).
Tri-Click non-amine controls
Tri-Click 4-bromo-1-butyne (TC-Br). To a solution of tri-
azide (0.100 g, 0.35 mmol) in 10 ml THF:H2O (1:1), Na-L-
ascorbate (5%) was added followed by CuSO4 (1%) under
a nitrogen atmosphere. To this solution 4-bromo-1-butyne
(0.1 ml, 1.05 mmol) was added. The reaction was allowed
to stir at rt for 24 h, a white precipitate was observed after
8 h. On the completion of the reaction, the white precip-
itate was collected by vacuum filtration and washed with
diethyl ether to afford the title compound as a white solid
(0.239 g, 0.35 mmol, 85%). MP: decomposed at 269◦C. 1H
NMR (400 MHz, CDCl3) : 7.10 (s, 3H), 5.58 (s, 6H), 3.56
(t, J = 6.7 Hz, 6H), 3.17 (t, J = 6.7 Hz, 6H), 2.35 (s, 9H). 13C
NMR (151 MHz, CDCl3) : 144.91, 139.70, 130.71, 121.10,
77.24, 77.03, 76.82, 48.93, 31.81, 29.31, 29.28, 16.67, 16.63.
Anal. Cal. for C24H30Br3N9: C, 42.13; H, 4.42; N, 18.42;
Br, 35.03. %Found: C, 42.41; H, 4.38; N, 18.50; Br, 34.65.
10294 Nucleic Acids Research, 2021, Vol. 49, No. 18
IR (ATR, cm–1): 3065, 1558, 1441, 1259, 1216, 1147, 1046,
925, 880, 812, 667, 553. ESI-MS m/z: [M + H]+ Cald for
C24H31Br3N9+: 682.0247; found 682.0212. [M + 2H]+2 Cald
for C24H32Br3N92+: 341.5; found 341.5.
Tri-click 2-methyl-3-butyne-2-ol (TC-iPrOH). To a so-
lution of triazide (0.430 g, 1.5 mmol) in THF:H2O (1:1,
15 ml), Na-L-ascorbate (10%, 0.45 mmol) was added fol-
lowed by CuSO4 (1%, 0.045 mmol) under a nitrogen at-
mosphere. To this solution 2-methyl-3-butyne-2-ol (0.382
g, 0.44 ml, 4.52 mmol) was added dropwise. The reaction
was stirred at 25˚C for 24 h. The resulting precipitate was
isolated by vacuum filtration and washed with cold EDTA
(0.1 M, 3 × 10 ml) and ice-cold water (3 × 10 ml). A white
solid was recovered in good yield, (570 mg, 1.06 mmol,
71%). MP: 274–275◦C. 1H NMR (600 MHz, (CD3)2SO)
: 7.65 (s, 3H), 5.66 (s, 6H), 5.08 (s, 3H), 2.44 (s, 9H),
1.42 (s, 18H). 13C NMR (151 MHz, (CD3)2SO) : 156.19,
139.61, 131.48, 120.44, 67.56, 48.67, 31.18, 16.87. Anal. Cal.
for C27H39N9O3: C, 60.32; H, 7.31; N, 23.45. %Found: C,
58.62; H, 7.26; N, 21.71. IR (ATR, cm–1): 3057, 1368, 1216,
1175, 1058, 955, 857,827, 806, 714. ESI-MS m/z: [M + Na]+
Cald for C27H39N9O3Na+: 560.3; found 560.3.
Polyamine controls
2,4,6-Tris-(aminomethyl)-mesitylene (T1). 2,4,6-Tris-
(aminomethyl)-mesitylene was prepared as per literature
(37,45). To a solution of triazide (1.00 g, 2.1 mmol) in
absolute EtOH (40 ml), Pd/C (10% w/w, 100 mg) was
added and the reaction was stirred under a H2 balloon
for 6 h. It was then filtered through a small pad of celite,
which was rinsed with EtOAc (3 × 15 ml). The filtrate was
concentrated to afford triamine (1.186 g, quant.) as a white
solid. MP: 149–150◦C. 1H NMR (600 MHz, CDCl3) :
3.95 (s, 6H), 2.48 (s, 9H). 13C NMR (151 MHz, CDCl3) :
138.13, 133.48, 40.84, 15.42. Melting point and 1H NMR
spectra were in agreement with literature data (37,46).
ATR-IR (cm–1): 3342, 2958, 2903, 2218, 1568, 1448, 1379,
1298, 1050, 861,620. ESI-MS m/z: [M + H]+ Cald for
C12H22N3+: 208.2; found 208.2.
2,4,6-Tris-(1,2-ethanediamine)-mesitylene (T2). The tar-
get amine scaffold was prepared by previously reported
methods with slight modifications (47). To a solution of
2,4,6-tris-(bromomethyl)-mesitylene (1.200 g, 3.0 mmol) in
dry THF (50 ml), ethylenediamine (8.04 ml, 120 mmol) was
added. The resulting solution was stirred at 25◦C until com-
plete conversion was observed by 1H NMR (24 h). Solvent
and excess diamine were removed under reduced pressure.
The resulting oil was solubilized in MeOH (30 ml) and KOH
(0.340 g, 6 mmol) was added and the inorganic salts were
precipitated by the addition of diethyl ether and removed
my filtration. The solvent was removed under reduced pres-
sure and product dried under schlenk line. The resulting
amine scaffold was identified as a thick oil (0.673 g, 1.99
mmol, 67%). 1H NMR (600 MHz, CDCl3) : 3.76 (s, 6H),
2.84–2.75 (m, 12H), 2.42 (s, 9H). 13C NMR (151 MHz,
CDCl3) : 135.03, 135.00, 52.84, 48.47, 41.68, 15.48. 1H
NMR was in agreement with literature data (47). ATR-IR
(cm–1): 3266, 2852, 1651, 1568, 1450, 1338, 1105, 1030, 814,
747. ESI-MS m/z: [M + H]+ Cald for C18H37N6+: 337.3;
found 337.3.
2,4,6-Tris-(1,3-propanediamine)-mesitylene (T3). The tar-
get amine scaffold was prepared by previously reported
methods with slight modifications (47). To a solution of
2,4,6-tris-(bromomethyl)-mesitylene (1.200 g, 3.0 mmol) in
dry THF (50 ml) 1,3-diaminopropane (10.02 ml, 120 mmol)
was added. The resulting solution was stirred at 25◦C un-
til the complete conversion was observed by 1H NMR (24
h). The product was worked up as previously stated and
the resulting amine scaffold was identified as a thick oil
(1.003 g, 2.65 mmol, 88%). 1H NMR (600 MHz, CD3OD)
: 3.86 (s, 6H), 2.98 (t, J = 7.1 Hz, 6H), 2.89 (t, J = 7.0 Hz,
6H), 2.46 (s, 9H), 1.87 (p, J = 7.0 Hz, 6H). 13C NMR (151
MHz, CD3OD) : 137.15, 135.46, 40.56, 29.53, 16.46.The
1H NMR spectra was in agreement with literature data (47).
ATR-IR (cm–1): 3256, 2922, 2856, 1567, 1452, 1377, 1327,
1103, 1026, 969, 815, 752. ESI-MS m/z: [M + H]+ Cald for
C21H43N6+: 379.3544; found 379.3542. [M + 2H]+2 Cald
for C21H43N6+2: 190.2; found 190.2. [M + 3H]+3 Cald for
C21H43N6+3 Cald 127.1; found 127.1.
DNA recognition procedures
Preparation of solutions. Tri-Click samples were initially
prepared in DMF and further diluted in HEPES buffer (80
mM). Metal complexes of the Tri-Click series were prepared
in-situ by co-incubating with copper(II) nitrate trihydrate,
manganese (II) chloride tetrahydrate or zinc(II) acetate di-
hydrate for 30 min at 37◦C prior to DNA addition.
DNA nuclease and condensation studies. Procedures were
adapted from previously published protocols, (28) where re-
actions were carried out in 80 mM HEPES (pH 7.4) unless
otherwise stated and followed the general procedure: a total
volume of 20 l with 25 mM NaCl, 400 ng pUC19 at vary-
ing concentrations of test compounds (0.25–500 M) were
incubated at 37◦C for either 90 min, 6, 12 or 24 h. Reac-
tions were quenched by adding 6× loading buffer (Fermen-
tas) containing 10 mM Tris–HCl, 0.03% bromophenol blue,
0.03% xylene cyanole FF, 60% glycerol, 60 mM EDTA and
samples were loaded onto an agarose gel (1.2%) containing
4 l EtBr. Electrophoresis was run at 70 V for 1 h in 1× TAE
buffer. DNA studies of TC1 (2.5–10 M) and various ra-
tios of copper (Cu(II):TC1 0:1–8:1) were conducted in the
presence of reductant were supplemented with 1 mM Na-L-
ascorbate and incubated at 37◦C for 30 min. Electrophore-
sis was carried out at 70 V for 90 min in 1× TAE buffer and
photographed using a UV transilluminator.
DNA damage studies of Cu(II)–TC1
Competitive ethidium bromide displacement assay. The
DNA binding affinity of TC1 was determined over a 2 h
time period using calf-thymus DNA and synthetic alternat-
ing co-polymers poly[d(A-T)2)] and poly[d(G-C)2] by ethid-
ium bromide fluorescence quenching in a similar manner
to the high throughput method previously reported by Kel-
lett et al. (48). TC1 (10 M) was treated with varying ratios
of copper(II) nitrate 0:1–8:1 in ctDNA, after which DNA
was treated with 3:1 Cu(II)–TC1 at various concentrations.
Each drug concentration was measured in triplicate, on at
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least two separate occasions, and the apparent binding con-
stants were calculated using Kapp = Ke × 12.6/C50 where
Ke = 9.5 × 106 M−1.
High resolution ESI-MS. Accurate mass spectrometry
analyses were conducted using a MaXis HD quadrupole
ESI-QTOF mass spectrometer. In a final volume of 1 ml,
a solution of TC1 (4 mM) was taken and mixed with vari-
ous equivalents of copper(II) nitrate trihydrate (0–32 mM)
to give a series of Cu(II):TC1 solutions ranging between 0:1
and 8:1 mM. Further dilution of these samples were made
as required to perform ESI-MS analysis. The relative inten-
sities of peaks in each pattern were combined and expressed
as a percentage of the total relative intensity given by the
three metal complex fragmentation patterns that were iden-
tified. Analyses were performed in ESI positive mode with
the capillary voltage was set to 4500 V, nebulizing gas at
0.6 bar, drying gas at 4 l/min at 180◦C in each case. The
TOF scan range was from 75 to 1600 mass-to-charge ra-
tio (m/z). Data processing was performed using the Com-
pass Data Analysis software version 4.3 (Bruker Daltonik
GmbH, Bremen, Germany).
Atomic force microscopy (AFM). AFM samples were pre-
pared according to previously reported methods(28) and
follow the general procedure detailed below in the presence
and absence of exogenous reductant. In the presence of re-
ductant: A total volume of 20 l containing pUC19 (200
ng), MgCl2 (10 mM), varying concentrations of test com-
pound Cu(II)–TC1 (0.5, 1.0, 7.5 and 10 M) in the pres-
ence of Na-L-ascorbate (1 mM) were incubated for 25 min
at 37◦C. Samples were further diluted to a DNA concentra-
tion of 2–3 ng/l in a final volume of 10 l with nuclease
free H2O, pipetted directly onto freshly cleaved mica and
incubated for a further 5 min. In the absence of reductant:
A total volume of 10 l final concentrations of 3 ng/l of
pUC19 (NEB, N3041), 5 mM MgCl and varying concen-
trations of test compound Cu(II)–TC1 (5, 10 and 30 M)
samples were incubated at 37◦C for 1 h. Mica was freshly
cleaved prior to incubating with samples (10 l, 5 min).
All samples were rinsed thoroughly with nuclease free water
(500 l) and dried under compressed air. AFM images were
acquired in ambient air with a commercial microscope, in
tapping-mode, using super sharp silicon cantilevers with a
40 N/m force constant. Topographic images were recorded
at a scanning rate of >1 Hz, and a resonance frequency of
about 300 kHz (nominal value). Images were processed us-
ing the WSxM software (49).
DNA cleavage in the presence of ROS scavengers. The as-
say was conducted according to recently reported meth-
ods (19,50). Briefly, to a final volume of 20 l, 80 mM
HEPES, 25 mM NaCl, 1 mM Na-L-ascorbate, and 400 ng
of pUC19 DNA were treated with varying drug concen-
trations Cu(II)–TC1 (2.5–10.0 M) in the presence ROS
scavengers; sodium azide (NaN3, 10 mM), 4,5-dihydroxy-
1,3-benzenedisulfonic acid (tiron, 10 mM), D-mannitol (10
mM), N,N′-dimethylthiourea (DMTU, 10 mM), and L-
methionine (10 mM). Solutions were briefly vortexed and
incubated at 37◦C for 30 min and electrophoresis was car-
ried out at 70 V for 1 h in 1× TAE.
DNA cleavage in the presence of repair enzymes. The as-
say was conducted according to methods recently reported
by Fantoni et al. (19) with slight modifications. Supercoiled
pUC19 DNA (400 ng) in 4 mM HEPES, 25 mM NaCl,
1 mM Na-L-ascorbate in a final volume of 20 l nuclease
free H2O, was pre-incubated with Cu(II)–TC1 for 30 min at
37◦C at 2.5–10.0 M. The following reactions were supple-
mented with associated buffers as per manufacturer’s rec-
ommendations. Repair enzymes Fpg, endonuclease (Endo)
III, Endo IV, Endo V and hAAG (2 units) were added to the
reaction mixture and incubated for 30 min at 37◦C. Samples
were denatured with 0.25% SDS, 250 g/ml proteinase K
and heated to 50◦C for 20 min. Reactions were quenched by
6× loading buffer, loaded onto agarose gels and subjected
to electrophoresis as stated above.
Intracellular DNA damage
The protocol was adapted from Singh et al. (51).
Blood sample collection. Blood samples from healthy vol-
unteers without having any pathology were collected from
the Hematology Lab at the Clinical Chemistry Department
at Sahlgrenska University Hospital, Gothenburg, Sweden.
Gradient centrifugation using Lymphoprep (Axis-Shield
PoC AS, Oslo, Norway) was used to collect peripheral
mononuclear blood cells (PBMCs).
Treatment of PBMCs with TC1 and copper (II) nitrate tri-
hydrate. 100 mM stock solutions of TC1 and copper (II)
nitrate trihydrate was prepared in DMSO and Milli Q®
(MQ) water respectively and stored at -20◦C until further
use. Co-incubation of TC1 at three different concentrations,
75, 100 and 300 M with a Cu(II) concentration of 300 M
was performed for 30 min at 37◦C in 1× RPMI. 5 × 105
PBMCs were introduced to the Cu(II)–TC1 complex and
incubated for 1 h on a thermal block at 37◦C. Final DMSO
concentrations did not exceed 0.1% (v/v).
Treatment of PBMCs with antioxidants. 100 mM stock
solutions of sodium pyruvate, tiron, L-histidine, and D-
mannitol were prepared in MQ water. Cells were pre-treated
with 1 mM scavengers for 2 h prior to Cu(II)–TC1 exposure.
Extraction of DNA. After drug treatment and antioxidant
studies, DNA was extracted using GenElute-Mammalian
Genomic DNA Miniprep Kit and eluted in 10 mM Tris–
Cl (pH 8.5). DNA concentrations were measured using
a NanoDrop 1000 spectrophotometer. Care was taken
to avoid loss of genomic integrity by using wide-bore
tips.
Fluorescent labeling of Cu(II)–TC1 induced DNA damage.
DNA (100 ng) was incubated with APE1, Fpg or Endo
III (2.5 U) in 1× CutSmart Buffer for 1 h at 37◦C. The in
vitro DNA repair was followed by 1 h incubation at 20◦C
with dNTPs (1 M of dATP, dGTP, dCTP, 0.1 M dTTP
and 0.1 M aminoallyl-dUTP-ATTO-647N, 1× NEBuffer
2 and DNA polymerase 1 (2.5 U) at 20◦C. Subsequently, the
reaction was terminated with 2.5 l of 0.25 M EDTA.
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Silanization of coverslips. Two silane molecules (3-
aminopropyl) triethoxysilane (APTES), allyltrimethoxysi-
lane (ATMS), and acetone were used to silanize standard
22 × 22 mm coverslips (52). The coverslips were carefully
put into an acetone solution containing 1% APTES and
1% ATMS (v/v) and coated for 1 h. Coated coverslips were
rinsed with acetone and MQ water to remove residues.
The air dried silanized coverslips were stored in a parafilm
sealed petri dishes and used within a week.
Staining and instrument. The Aminoallyl-dUTP-ATTO-
647N labelled DNA samples were diluted with 0.5× TBE
and were stained with 320 nM YOYO-1 (Invitrogen). 2 l -
mercaptoethanol was added in total volume of 100 l. The
DNA samples were extended by placing the 3.8 l solution
at the interface of the silanized coverslip and a microscopy
slide (VWR Frosted). Zeiss Observer.Z1, equipped with an
Andor iXON Ultra EMCCD camera and a Colibri 7 LED
illumination system was used to obtain the fluorescence im-
ages. Each image consisted of two colours, YOYO-1 (green),
and aminoallyl-dUTP-ATTO-647N (red) using appropriate
filters band-pass excitation filters (475/40 and 640/30 nm)
and bandpass emission filters (530/50 and 690/50 nm), re-
spectively with exposure times of 10 ms and 500 ms.
Software analysis
AFM images were processed using the WSxM software
to remove the background slope and normalize the z-
scale across all images, no additional filtering was per-
formed (49). Microscopy images were analysed using a
custom-made software. The total number of colocalized
aminoallyl-dUTP-ATTO-647N labels in an image set was
divided by the total DNA length in pixels to get the ra-
tio as DNA damage/length. The final values were de-
picted as Dots/MBp. It was calculated by stretching lambda
DNA molecules (48 502 bp) in similar buffered condi-
tions where we observed that 1 m = ∼3000 bp. Band den-
sitometry was quantified using the Image J software pack-
age were each reaction was carried out in triplicate.
Statistics
Intracellular DNA damage and band densitometry stud-
ies were performed in triplicate and analyzed in Graph-
Pad Prism using un-paired T tests. The data was consid-




We employed the CuAAC click reaction to gen-
erate TC compounds (TC1-7) described in Figure
1A and B. The parent 1,3,5-tris(azidomethyl)-2,4,6-
trimethylbenzene (triazide) was prepared using 2,4,6-
tris(bromomethyl)mesitylene in the presence of excess
sodium azide (Supplementary Figure S1a). Initial ex-
periments to identify suitable conditions to click alkyne
substrates to each site of triazide focused on studying
a simple 2-methyl-3-butyn-2-ol substrate with CuSO4
(1%) in the presence of ascorbate (10%). This reaction
proceeded at room temperature with the product (TC-
iPrOH, Figure 1C) precipitating in reasonable yield.
Following this reaction, nine alkyne-amines varying from
simple propargylamine to aromatic ethynylanilines, were
identified as potential substrates (Figure 1B). Each group
contains either a primary, secondary or tertiary amine
and our overall aim was to develop nine compounds.
The first set of TC agents (TC1-3) was prepared using
propargylamine (1◦), N-methylpropargylamine (2◦), and
N,N-methylpropargylamine (3◦). For TC1, initial experi-
ments focused on treating triazide with propargylamine
using typical catalytic conditions required for click chem-
istry, including CuSO4 or CuBr with added ascorbate but
in all cases no product was isolated. Further attempts
using anaerobic conditions under reflux and with excess
copper also proved unsuccessful. Similar difficulties were
encountered during the attempted preparation of TC2, sug-
gesting the use of primary or secondary amines inhibit this
particular CuAAC reaction (53). To probe this further, the
reaction involving the tertiary N,N-methylpropargylamine
was investigated and this afforded the desired TC3 click
product at the first attempt. Amine protection chemistry
was then investigated where Boc-protected propargy-
lamine and N-methylpropargylamine were examined in
the CuAAC reaction with triazide. These reactions were
successful but required purification by column chromatog-
raphy and subsequent difficulties were encountered in the
removal of the Boc-protecting groups from both products.
In keeping with the scope of this study, the click reaction
was revisited using a broader range of conditions. The
solvent mixture was changed from THF to t-BuOH––a
more polar protic solvent used in the first click chemistry
reactions reported by Sharpless (30)––and the preparation
of TC1 and TC2 was then achieved with propargylamine
and N-methylpropargylamine. These reaction conditions
were further optimised through use of a t-BuOH:H2O (1:1)
solvent mixture (supplementary section S-1).
The next group of alkyne-amines investigated was
the ortho-substituted 3-ethynylanilines (Figure 1B). Sim-
ilar to the propargylamine series, 3-ethynylaniline (1◦)
and 3-ethynyl-N-methylaniline (2◦) did not yield the de-
sired Tri-Click products (TC4 and TC5) but 3-ethynyl-N-
methylaniline (3◦) was successful without the use of pro-
tection chemistry and provided a straightforward route
to TC6. Ideally, click chemistry reactions should be per-
formed in aqueous conditions without the need for protect-
ing group but since the 1◦ and 2◦ ethynylanilines are water
insoluble, an organic solvent was required which resulted
in the use of Boc-protection chemistry to prepare TC4 and
TC5 (Figure 1A, route 3 and Supplementary Figure S1). In
this case, deprotection was easily achieved through excess
TFA with the desired Tri-Click products isolated by flash
chromatography.
To complete the series, the para-substituted 4-
ethynylanilines (Figure 1B) were investigated as a possible
route toward developing the final three compounds. In par-
allel to earlier observations, 4-ethynyl-N,N-dimethylaniline
(3◦)––generated by the methylation of 4-ethynylaniline
(Supplementary Figure S1c)––provided a straightforward
route for generating TC7 (Figure 1A, route 2). However,
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Figure 1. (A) General synthetic routes for the Tri-Click series. Route 1: alkyne functionalised primary and secondary amines were coupled to triazide
using the CuAAC reaction. Route 2: tertiary amines where clicked with Cu(I). Route 3: Cu(I) click conditions of Boc-protected benzyl substituted amines
followed by deprotection. (B) Structures of successful and attempted click rections of alkyne-amines. (C) Tri-Click SAR controls. Clicked derivatives with
no terminal amines TC-Br and TC-t-BuOH and simplified polyamine analogues T1-3.
4-ethynylaniline could not be clicked to triazide and so
the Boc-protected 4-ethynylaniline was prepared but no
conditions––including long reaction times and high cat-
alyst loading––were found to promote the click reaction
(Supplementary Figure S2 and Supplementary Table S1).
Methylation of the Boc-protected 4-ethynylaniline did not
proceed in order to generate 4-ethynyl-N-methylaniline
and the subsequent 2◦ Tri-Click product. The final Tri-
Click library therefore contained seven compounds: the
propargylamine series (TC1-3) that contain simple amine
handles linked by one carbon spacer to the triazole ring;
the 3-ethynylanilines (TC4-6); and 4-ethynylaniline (TC7).
Prior to DNA screening experiments, a series of controls
were prepared based on (a) the Tri-Click scaffold lacking
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an amine handle (TC-Br and TC-iPrOH) and (b) simplified
tripodal amines lacking the triazole group (T1–T3) (Figure
1C and Supplementary Figure S3). The purpose of these
controls was to ensure any novel nucleic acid interactions
observed were not arising from either the amine or the
triazole scaffold alone.
Screening for innate DNA binding interactions
The DNA recognition properties of the TC series, along
with control compounds, were probed using electrophoresis
experiments with supercoiled pUC19 DNA. TC1 was exam-
ined across a wide concentration range and found to con-
dense DNA at high concentrations between 250 and 500
M (Figure 2A, lanes 11–13). TC2-7 were then examined
at high loading only (100 and 500 M) with slight aggre-
gation effects observed for TC6 and TC7 (Figure 2B, lanes
10–13). The control agent TC-Br had only a mild conden-
sation effect at 500 M while TC-iPrOH had no effect on
pUC19 (Figure 2c). The tripodal amine controls were more
active at condensing DNA; T1 was observed to mildly con-
dense pUC19 while T2 and T3 were highly active at 100
M which was not surprising since both agents can carry
a 6+ cationic change and are flexible. Taken together, these
results indicate that electrostatic interactions can play a role
in DNA aggregation but the TC series are not potent DNA
condensation agents compared to simple polyamines or C3-
symmetric opioids (28).
Nuclease activity in the presence of first row metal ions
The interactions of the TC series was next examined in
the presence of first row metal ions. Given the presence of
three potential am(m)ine metal ion binding sites, Tri-Click
scaffolds were pre-incubated with three molar equivalents
of either Cu(II), Mn(II) or Zn(II) ions––all of which are
known to catalyse DNA strand scission when complexed to
specific ligands (2,54–56)––prior to incubation with DNA
for a period of 24 h at pH 7.2 (Figure 3A–C). Of all the
reactions studied, the 3:1 Cu(II):TC1 complex (hereafter
referred to as Cu(II)–TC1) was the only complex to dis-
play DNA damaging properties (Figure 3C). Here, super-
coiled pUC19 was completely relaxed to its open circular
form (OC) indicating the formation of single strand breaks
(SSBs). Since these reactions were conducted in the absence
of exogenous reagents (i.e. added reductant or peroxide)
the Cu(II)–TC1 complex appears capable of ‘self-activating’
chemical nuclease activity––an effect previously observed
for several polynuclear Cu(II) complexes (22) and mononu-
clear Cu(II) complexes of marine alkaloids (57,58). To es-
tablish the role of am(m)ine coordination in SSB formation,
the reactions of TC ligands with Cu(II) were repeated in
acidic buffer (pH 4.0) (Supplementary Figure S4). In these
conditions the chemical nuclease activity of Cu(II)–TC1
was negligible indicating that metal ion binding, and thus
chemical nuclease activity, is inhibited due to the protona-
tion of each primary am(m)ine site in TC1. Finally, the ac-
tivity of Cu(II)–TC1 was monitored at lower concentrations
and shorter timeframes (again in the absence of exogenous
reagents) at neutral pH. After 90 min, the presence of 5 M
of Cu(II)–TC1 initiates SSB formation with complete con-
version to the nicked form at 50 M exposure (Figure 3D).
Extending the incubation time to 6 h showed that more ef-
ficient DNA cleavage could be obtained with 5 M of TC1
(Figure 3E).
Copper(II) ion DNA damage dependency
To determine the optimum copper binding ratio required
for DNA damage, a series of experiments were designed to
identify the DNA binding and nuclease activity at differ-
ent ratios of Cu(II):TC1 ranging from 1:1 to 8:1. In par-
allel, high resolution ESI-MS analyses were conducted us-
ing the same Cu(II):TC1 ratios. Firstly, DNA binding was
examined through an ethidium bromide (EtBr) competitive
displacement assay with calf thymus DNA (ctDNA). Here,
the percentage displacement of bound EtBr was plotted as
a function of Cu(II):TC1 (10 M TC1) and data were com-
pared to a Cu(II) nitrate control in the absence of TC1 (Fig-
ure 4A). It is clear the DNA binding activity of TC1 is de-
pendent on copper(II) with the percentage of bound EtBr
diminishing as a function of metal ion concentration. DNA
cleavage activity was then investigated using pUC19 plas-
mid DNA. Here, solutions of Cu(II):TC1 (again ranging
between 1:1 to 8:1) were taken and exposed to the plas-
mid across a 2.5–10 M [TC1] concentration range in the
presence of added ascorbate (Figure 4B). Results were then
compared to control experiments of copper(II) nitrate in the
absence of TC1. No significant nuclease activity was evi-
dent at ratios of 1:1 and 2:1 of Cu(II):TC1. However, higher
equivalents of 3:1 and 4:1 Cu(II):TC1 were active with the
formation of SSBs and DSBs emerging along with com-
plete degradation at higher concentrations. Complex ratios
exceeding 4:1 Cu(II):TC1 displayed rampant DNA degra-
dation (Supplementary Figure S5). Copper-mediated DNA
damage in the absence of TC1 revealed significantly lower
levels of activity; here, the onset of nicking was detected at
15 M with higher levels of damage occurring at 30 M
and above. Finally, to identify the predominant Cu(II):TC1
species present at each of the tested ratios, ESI-MS analysis
was performed. From the Cu(II):TC1 ratios prepared (1:1
to 8:1), attempts were made to identify three complexes cor-
responding to mono-cationic forms of mono-, di-, and tri-
nuclear species: [Cu(TC1)(NO3)]+; [Cu2(TC1)(NO3)3]+ and
[Cu3(TC1)(NO3)5]+ respectively. The distribution of these
three fragments were then normalised as a percentage of
the total relative intensity of all three fragments (Figure 4C
and Supplementary Table S2). This analysis revealed simul-
taneous yet independent 1:1, 2:1, and 3:1 complex forma-
tion in situ upon increasing addition of copper(II) nitrate.
Significantly, this pattern revealed a sequential and propor-
tional transition from an initially predominant mononu-
clear species to a mixture of complexes dominated by the
trinuclear agent. Comparing these results with the activity
observed in Figure 4A and B reveals an interesting correla-
tion. The 1:1 complex is inactive and while the emergence of
the 2:1 species enhances DNA binding, its DNA damaging
properties remain low. Thus, it is not until the 3:1 complex
emerges that a potent combination of DNA binding and
cleavage activity is produced.




Figure 2. DNA condensation of supercoiled pUC19 exposed to increasing concentrations of (A), TC1 (0.5 – 500 M) (B), Tri-Click samples TC2-7 and
(C), controls at 100 and 500 M. All reactions were carried out in neutral HEPES buffer (80 mM, pH 7.2) at 37◦C for 90 min.
DNA binding and time-course cleavage interactions
To establish how copper(II) binding influences DNA recog-
nition, apparent DNA binding studies were conducted
with calf-thymus DNA (ctDNA) along with alternating co-
polymers poly[d(A-T)2] and poly[d(G-C)2]. These experi-
ments determine the indirect binding constant based on
the ejection of bound EtBr, which serves as an interca-
lating reporter. The TC1 ligand alone demonstrated mod-
erate DNA binding constants of ∼106 M–1 with ctDNA
and A-T duplex polymers while a lower value of ∼105 M–1
was observed with poly[d(G-C)2]. However, in the presence
of three copper(II) nitrate ions, binding increased by 10-
and 100-fold (∼107 M–1) in all three of the duplexes (Fig-
ure 5A–C). Although the binding constants of Cu(II)–TC1
did not show specificity for A–T or G–C rich DNA, they
were nonetheless comparable to the high-affinity intercala-
tor actinomycin D and the minor groove binder netropsin
(59).
Next, DNA cleavage by Cu(II)–TC1 was mapped using
a time-course study (30 min to 24 h) with the Cu(II)–TC1
(25 M) in the absence of reductant (Figure 5d and Sup-
plementary Figure S6). Band densitometry analysis showed
almost 50% SSB formation after 2.5 h and >95% of the
plasmid was nicked by 7.5 h. The appearance of double
strand breaks (DSBs) could be detected after 24 h but only
at limited concentration (∼5%) and after the appearance
of SSBs indicating they originate from two independent
nicking events. In the absence of reductant, Cu(II)–TC1
(i.e. the 3:1 Cu(II):TC1 complex) clearly produces SSBs
but to better understand how this complex might behave
biologically, the addition of endogenous reducing agents
were employed to mimic physiological conditions. Here,
strand scission was catalysed in the presence of the natu-
ral reductant, Na-L-ascorbate, where SSBs and DSBs oc-
cur at low concentration (2.5 M of TC1) and short re-
action times (30 min, Figure 4B), thereby suggesting an
oxidative cleavage mechanism is at play. Another reducing
agent, 3-mercaptopropionic acid (MPA), (60,61) was exam-
ined under identical conditions, however no apparent cleav-
age of the plasmid was observed (data not shown). This phe-






Figure 3. Nuclease activity on supercoiled pUC19. DNA cleavage in the presence of 3 equivalents (A), Mn(II), (B), Zn(II) and (C) Cu(II) over 24 h.
Cleavage reactions with increasing concentrations of TC1 with 3 equivalents of copper(II) nitrate over (D), 1.5 h and (E), 6 h. All reactions were carried
out in HEPES (80 mM) with no reductant.
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Figure 4. Identification of copper(II) ion DNA recognition and damage dependency. (A) Competitive EtBr displacement in ctDNA by mixtures of
Cu(II):TC1. The concentration of Cu(II) nitrate was varied against a fixed concentration of TC1 (10 M). (B) Nuclease activity of Cu(II):TC1 and a
copper(II) nitrate control. Samples were incubated with supercoiled pUC19 for 30 min in the presence of 1 mM ascorbate. (C) Accurate mass spectrometry
analyses of Cu(II):TC1 solutions (expressed as normalised percentage of the total relative intensity).
nomenon has previously been observed where exchanging
redox initiators strongly influences DNA cleavage (61,62).
Atomic force microscopy (AFM) analysis of DNA damage
Using gel electrophoresis we have shown that Cu(II)–TC1
is capable of cleaving supercoiled plasmid DNA to open
circular and linear forms via SSB and DSB formation. To
study this conformational change in more detail, AFM
measurements were undertaken with pUC19 exposed to
Cu(II)–TC1. In the presence of excessive reductant (Na-
L-ascorbate), DNA remained predominantly in its super-
coiled state, however the addition of 500 nM of Cu(II)–TC1
initiated single strand breaks that were visualised (Figure
6A). Points where ligand-DNA binding occur were iden-
tified as increases in the height profile of circular struc-
tures (Figure 6B). An increase in complex concentration
(1.0 M) rendered plasmid DNA predominantly in its
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Figure 5. (A) Competitive EtBr displacement in canonical dsDNA and alternating co-polymers. (B) Apparent DNA binding constants calculated by 50%
reduction in EtBr fluorescence (actinomycin D and netropsin values were earlier reported in (59)). (C) Proposed simplified structure of Cu(II)–TC1 with
3 equivalents of copper(II) (counterions and charge omitted). (D) Band densitometry of Cu(II)–TC1 nuclease activity and three forms of plasmid DNA:
supercoiled (form I), SSBs (form II) and DSBs (form III).
Figure 6. Atomic force microscopy (AFM) images of Cu(II)–TC1 treated supercoiled pUC19 (3 ng/l) in the presence of reductant (A–D: 0.5, 1.0, 7.5 and
10 M of Cu(II)–TC1) and absence of reductant (E–G: 5, 10 and 30 M of Cu(II)–TC1; H: zoom of G).
open circular form (Figure 6B) with complete degrada-
tion reached at 7.5–10 M exposure (Figure 6C and D).
DNA damage was also visualised in the absence of reduc-
tant at a low concentration (5 M) of the complex (Fig-
ure 6E). Small compact clusters of fragmented DNA were
intermediately observed and these small aggregates are ev-
ident in Figure 6F and G where the complex concentra-
tion (again in the absence of reductant) was increased to 10
and 30 M, respectively. On closer inspection of the clus-
ter present in Figure 6G, it can be clearly seen that small
portions of fragmented DNA surround the compact parti-
cle (Figure 6H). These compacted DNA fragments could
not be visualised through gel electrophoresis due to their
small size, however AFM analysis provides evidence of this
interaction by the moderate condensation effects of the
complex.
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Figure 7. Probing the DNA damage mechanism of Cu(II)–TC1 using ROS scavengers. DNA cleavage reactions in the presence of (A), NaN3 and tiron
(B), D-mannitol, DMTU and L-methionine.
Probing the DNA cleavage mechanism with radical scav-
engers and BER enzymes
The Cu(II)–TC1 DNA damage mechanism was probed in
vitro, where the role of radical species were analyzed with
ROS-specific scavengers and spin-trapping agents: (19,22)
NaN3, tiron, D-mannitol, N,N′-dimethylthiourea (DMTU)
and L-methionine. These antioxidants can sequester sin-
glet oxygen (1O2), superoxide (O2•−), the hydroxyl radi-
cal (•OH), hydrogen peroxide (H2O2) and hypochlorous
acid (HOCl) or a combination thereof (see inset table Fig-
ure 7). In these experiments, the delayed onset of SSB
formation and the inhibition of DSBs were evident (Fig-
ure 7). H2O2 was identified as the most prevalent radi-
cal species required in the cleavage mechanism as DMTU
(N,N’-dimethylthiourea) inhibited the complete transfor-
mation of supercoiled DNA to nicked open circular DNA.
The •OH scavenging agent D-mannitol had almost no in-
fluence on DNA cleavage, but L-methionine inhibited the
formation of DSBs which may be attributed to scavenging
of H2O2. Finally, the superoxide radical also appears to be
important in the DNA cleavage mechanism since the in-
troduction of tiron prevented DSB formation and delayed
the onset of SSBs. Taken together, these results suggest the
DNA damaging mechanism by Cu(II)–TC1 does not follow
classic Fenton chemistry (which is dependent on diffusible
•OH radical generation), but instead follows a superoxide
dismutase (SOD) type mechanism, whereby electron trans-
fer from a reduced Cu(I) centre promotes the formation of
O2•− (or a metal-superoxo species), which is then converted
to H2O2 by a second Cu(I) metal centre. Therefore, it might
be the case that O2•− does not promote DNA damage di-
rectly, but that tiron simply impedes the downstream for-
mation of the peroxide (or metal-peroxo Cu(II)–OOH type)
cleavage species.
In order to examine the oxidative damage mechanism in
greater detail, base excision repair (BER) enzymes, which
can recognise specific lesion-specific modifications associ-
ated with oxidative damage were employed. This method
was adapted from Fantoni et al. (19) with slight modifi-
cations. Repair proteins that recognise base-specific DNA
lesions––or a small a small set of lesions with a common
structural motif––are known as glycosylases and carefully
remove their cognate damaged bases to yield abasic sites.
Specific repair endonucleases can then recognise these AP
(apurine/apyrimidine) sites and mediate strand nicking ad-
jacent to the base-free lesion to create a single nucleotide
gap that is filled by the insertion of a new base. The BER and
endonuclease enzymes employed in this study are listed in
Figure 8 (table inset) and initial experiments involved treat-
ing pUC19 with each enzyme to ensure that the plasmid
was free of existing lesions (Supplementary Figure S7). Ex-
periments were then designed to initiate DNA cleavage us-
ing a control hydroxyl radical (•OH) generated from a Fen-
ton Cu2+/H2O2 reaction alongside the Cu(II)–TC1 com-
plex. After 30 min of continuous exposure to the complex
(used to initiate DNA damage), specific BER enzymes were
introduced and the reactions were allowed to incubate for
a further 30 min with results compared to control experi-
ments lacking repair enzymes. In the copper-mediated Fen-
ton reaction, DNA damage was inhibited by Fpg and Endo
III, which indicates strand breaks are mediated by oxidised
purine and pyrimidine bases generated by the hydroxyl rad-
ical (Figure 8A). Reaction conditions for the Cu(II)–TC1
(2.5–7.5 M) were optimised to initiate SSB and DSB cleav-
age of supercoiled pUC19 (Figure 8B, lanes 2–4). In all
cases, the presence of specific BER enzymes inhibited DSB
formation since no linearised DNA was detected. In the
presence of Fpg and Endo III, a significant reduction in SSB
formation occurred thereby providing protection of intact
plasmid DNA. In conjunction with the inhibition profile of
Endo IV (and to a lesser extend Endo V), these results sug-
gest the Cu(II)–TC1 complex can oxidise both purine and
pyrimidine bases and promote the formation of abasic sites.
APE1 selectively repairs Cu(II)–TC1 mediated single-strand
breaks in PBMCs
Intracellular DNA damage mediated by Cu(II)–TC1
was examined using peripheral blood mononuclear cells
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Figure 8. Probings DNA damage mechanism through repair endonuclease to identify damage lesions. (A) Fenton reagents, Cu(II) + H2O2 produce •OH
and (B) Cu(II)–TC1. pUC19 DNA was preincubated with Cu(II)–TC1 or Fenton reagents for 30 min at 37◦C prior to repair enzyme addition and further
incubated for 30 min. Enzymes were denatured for 20 min (50◦C) and subjected to electrophoresis.
(PBMCs). PBMCs were selected for this study as they
are primary, non-immortalised cells and therefore provide
a suitable representative model for accurate DNA repair
mechanisms. An assay was designed (Figure 9A and B)
whereby DNA extracted from metal complex-treated cells
was initially exposed to specific BER enzymes and in a sec-
ond step, DNA polymerase 1 was introduced with a fluores-
cent dNTP (aminoallyl-dUTP-ATTO-647N). Later, a dye
(YOYO-1) was used to stain the DNA backbone and in-
dividual DNA molecules were stretched on silanized glass
coverslips, where image analysis determined the extent of
DNA damage by quantifying the incorporation of repaired
bases on the single DNA molecule level (cf. Figure 9C)
(51,63–65). PBMCs were exposed to Cu(II)–TC1 and in-
tracellular SSBs were quantified (Figure 9d). In these ex-
periments, the concentration of Cu(II) was kept constant
(300 M) while the TC1 concentration was varied to ex-
amine TC1:Cu(II) ratios from 1:1 to 1:4. Compared to un-
treated control cells, SSB formation increased ∼5.0-fold
as the concentration of Cu(II)–TC1 increased to 300 M.
Next, PBMCs were incubated prophylactically with specific
antioxidants––sodium pyruvate (H2O2), tiron (O2•−), L-
histidine (1O2) or D-mannitol (•OH)––prior to the introduc-
tion of the Cu(II)–TC1 complex (Figure 9d). With sodium
pyruvate, the decrease in Cu(II)–TC1-mediated SSBs was
highest indicating that H2O2 is required in the DNA cleav-
age mechanism, in agreement with the in vitro experiments.
Overall, the inhibition of SSB formation follows the trend:
sodium pyruvate >> L-histidine > tiron > D-mannitol, in-
dicating again that superoxide is not primary to SSB for-
mation. Next, three different BER enzymes, Fpg, Endo III,
and APE1 (derived from an AP endonuclease family simi-
lar to Endo IV) (66) were employed to quantify the selec-
tive repair of SSBs. In PBMCs treated with Cu(II)–TC1,
a SSB fold increase of ∼1.1 (FpG), ∼0.8 (Endo III) and
∼3.7 (APE1) was detected, when compared to only DNA
polymerase 1 treated Cu(II)–TC1 samples (Figure 9E). That
APE1 was the most efficient enzyme in repairing the SSBs
indicates that the majority of lesions generated by this com-
plex are apurinic/apyrimidinic sites. In summary, these re-
sults strongly overlap with in vitro analysis and demon-
strate abasic sites generated by a TC1-Cu-peroxide medi-
ated mechanism leading to the formation of intracellular
SSBs.
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Figure 9. DNA damaging potential and effect of antioxidants in isolated PBMCs. (A) Illustration of sample collection and treatment: 1. PBMCs isolated
from blood samples taken from healthy volunteers; 2. isolated cells treated with Cu(II)–TC1 in the presence or absence of ROS scavengers (pyruvate,
tiron, L-histidine, D-mannitol). (B) Schematic of DNA labelling process: 3. DNA with damaged bases (purple) was extracted from PBMCs; 4. BER
enzymes (Fpg, Endo III or APE1, cyan) remove oxidized bases; 5. fluorescent dNTPs (aminoallyl-dUTP-ATTO-647N, red) were incorporated by DNA
polymerase 1 (grey); 6. dsDNA was labelled with YOYO-1 (green). (C) Representative microscopic images of labelled DNA from non-treated PBMCs
(top) and Cu(II)–TC1 treated cells (bottom, Cu(II):TC1 ratio 1:1, 300:300 M). Scale bar = 10 m. Extended panel shown in Supplementary Figure S8.
(D) DNA damage at varying TC1 concentrations with fixed Cu(II) concentration with and without radical scavengers (Cu(II):TC1 ratio 4:1, 300:75 M).
(E) Identification of specific DNA damage lesions with individual BER enzymes (Cu(II):TC1 ratio 4:1, 300:75 M). Enzyme and scavenger controls are
shown in Supplementary Figure S9.
CONCLUSION
The discovery of new metallodrugs with alternative modes
of action is important not only to overcome resistance
factors, but also in treating recalcitrant cancers where no
(or severely limited) treatment options remain. In this
work, we identified a click chemistry-based strategy to pro-
duce bioactive polynuclear complexes. A series of alkyl
and aromatic amines with alkyne groups were developed
and clicked to a 1,3,5-triazide mesitylene core to produce
a library of polyamine ligands we called the Tri-Click
(TC) series. Although several examples of DNA reactive
polynuclear copper(II) complexes have been reported (67–
69)––including di- and tri-nuclear species containing a cen-
tral aryl core(25,60)––click chemistry has not been em-
ployed to furnish any of these existing libraries. Indeed, with
the exception of G-quadruplex stabilising agents, (34) click
chemistry has not been widely employed to design small
molecule metallodrugs with nucleic acid recognition prop-
erties. From the isolated library, the simplest compound
(TC1) was identified as a copper(II) binding ligand with
potent chemical nuclease activity. TC1 was produced by
reacting a primary amine, propargylamine, with mesity-
lene triazide and it appears this specific combination is re-
quired for copper-mediated nuclease activity. Significantly,
when secondary and tertiary amine tripodal derivatives
(TC2 and TC3) were investigated no DNA damage was ob-
served. Aryl amines were also found to be inactive (includ-
ing the primary amine ethynyl-aniline) suggesting that a
conserved arrangement between the primary amine and
the triazole group is required for copper-mediated DNA
cleavage. Similar to classical chelators that mediate DNA
damage in the presence of copper ions, (17) TC1 contains
N,N donors that are capable of forming a 5-membered ring
with copper (one from the primary amine and a second
from the 3′ imine of the triazole ring). Coordination of
copper is essential for DNA oxidation since protonation
of the am(m)ine group in acidic buffer (pH 4.0) provides
no associated cleavage activity. In situ ESI-MS analysis of
Cu(II):TC1 solutions (1:1 to 8:1) identified the presence of
three mono-cationic species corresponding to mono-, di-
, and tri-nuclear forms of the complex: [Cu(TC1)(NO3)]+;
[Cu2(TC1)(NO3)3]+; and [Cu3(TC1)(NO3)5]+, respectively.
Correlating ESI-MS results with the biological activity of
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each Cu(II):TC1 ratio revealed the 3:1 complex as the ac-
tive agent which produces a potent combination of DNA
binding and cleaving activity.
The binding affinity of TC1 to duplex DNA is moderate
(105 – 106 M–1) but in the presence of titrated copper(II)
activity increases to 107 M–1 for calf thymus and AT and
GC co-polymers. This affinity places it in line with clas-
sical DNA recognition agents such as netropsin, dactino-
mycin and several state-of-art intercalating metallodrugs
(18) but it appears Cu(II)–TC1 does not interact purely by
groove binding or intercalation. Subsequent AFM analysis
of Cu(II)–TC1 with plasmid DNA in the absence of reduc-
tant demonstrated the emergence of compact clusters sur-
rounded by small portions of fragmented DNA. Based on
this evidence it appears Cu-TC1 interacts electrostatically
with DNA and initiates condensation that involves aggrega-
tion of sheared nucleic acid fragments that arise from SSBs.
In a broadly similar vein, phosphate clamping polynuclear
platinum complexes such as TriplatinNC which contain
three trans-symmetric Pt(II) ions––and which also carry a
net +6 cationic charge––demonstrate high DNA binding
affinities and are potent condensation agents of DNA du-
plexes and nucleic acids in general (70–72). Polynuclear cop-
per complexes are known to interact electrostatically with
the phosphate group with a recent example [Cu2(tetra-(2-
pyridyl)-NMe-naphthalene)]2+ (Cu2TPNap) demonstrat-
ing combined major groove residency and metal ion-
mediated phosphate binding (23).
Cu(II)–TC1 demonstrates ‘self-activating’ DNA cleav-
age and is capable of mediating single strand breaks in
the absence of an external (exogenous) reducing agent. A
limited number of other copper(II) complexes––including
tambjamine E and prodigiosin polypyrrole-based ma-
rine alkaloids, (57,58) macrocyclic colibactin, (12) and
polynuclear agents including Cu2TPNap (23) and Cu-Oda
([{Cu(Phen)2}2(-Oda)]2+) (73)––can also damage DNA
under these conditions with several demonstrating potent
anticancer and antimicrobial properties (Supplementary
Figure S10). These complexes are hypothesised to produce
Cu(I) via autocatalysis involving one electron transfer from
either a neighbouring metal ion (in polynuclear systems)
or directly from coordinated polypyrrole ligands that oxi-
dise to -radical cations. In the presence of added ascor-
bate, the Cu(I)–TC1 complex is generated and is a potent
DNA oxidant inducing SSBs and DSBs (arising from prox-
imate SSBs or clustered damage) at low micromolar concen-
trations. This enhanced activity was corroborated by AFM
imaging in the presence of ascorbate where SSBs and DSBs
were identified across a 0.5–10 M concentration gradient.
DNA damage assays, performed both in vitro and in periph-
eral blood mononuclear cells (PBMCs), were then applied
to probe the mechanism of copper-mediated DNA damage.
Firstly, hydrogen peroxide appears crucial for strand break-
ages as sequestering this in vitro with DMTU and intracel-
lularly with sodium pyruvate impedes DNA damage. The
superoxide anion was also implicated since pUC19 DNA
was protected in the presence of tiron, however, negligible
protection was afforded to PBMCs pre-treated with tiron
indicating a mechanism independent of diffusible superox-
ide. In vitro experiments with BER enzymes revealed the
primary lesions generated are oxidised purine and pyrim-
idine bases recognised by Fpg and Endo III and, to a lesser
extent, abasic sites that were recognised by Endo IV. This
activity was then compared to intracellular results from
PBMCs exposed to Cu(II)–TC1 where BER enzymes, to-
gether with fluorescently modified dNTPs, identified abasic
sites––specifically recognised by APE1––as the major cellu-
lar lesion produced by this complex. Finally, the nuclease
activity produced by Cu(II)–TC1 appears quite different to
that of established polyamines (e.g. spermine, putrescine),
which are known to modulate DNA damage and repair at
abasic sites (74–77).
Several conclusions can be drawn by comparing in vitro
quenching data and results from intracellular trapping ex-
periments (where available) to other ‘self-activating’ cop-
per complexes. Firstly, polypyrrole-based marine alkaloids
prodigiosin and tambjamine E along with macrocyclic col-
ibactin all cleave plasmid DNA in vitro without exogenous
reductant using a peroxide-dependant mechanism inhibited
by the catalase enzyme (12,57,58). All three natural prod-
ucts maintain their in vitro activity in the presence of su-
peroxide dismutase (SOD) and hydroxyl radical scavengers
(D-mannitol or tert-butyl alcohol) indicating a mechanism
that is independent of diffusible superoxide and hydroxyl
radicals. The major groove binder Cu2TPNap also displays
self-activation and it appears diffusible free radicals are sim-
ilarly not involved in the cleavage process since 8-oxo-dG
is not generated (23). However, in contrast to naturally oc-
curring systems, strand breaks were completely inhibited in
vitro by sequestering superoxide with tiron and SSBs and
DSBs attenuated in the presence of pyruvate. DNA cleav-
age by Cu-Oda also requires superoxide with in vitro and
intracellular activity impeded by tiron (22). However, un-
like Cu2TPNap and naturally occurring polypyrroles, DNA
cleavage is not affected by hydrogen peroxide scavengers.
Instead, the complex mediates intracellular singlet oxygen
production in its doubly reduced form (i.e. where both cop-
per ions are in the + 1 oxidation state) (73). Considering
these classes of ‘self-activated’ systems, the DNA damag-
ing activity of Cu(II)–TC1 appears closely related to the
copper(II) complexes of polypyrrole-based alkaloids and
macrocyclic colibactin since: (a) activity is dependent on hy-
drogen peroxide; (b) the superoxide radical is not involved
during the cellular cleavage process and (c) singlet oxygen
and Fenton-type products are not involved in the DNA
damage mechanism.
In summary, we identified and characterised a new click
chemistry method to produce novel polynuclear DNA
damaging metallodrugs. Conclusive evidence was provided
demonstrating that a lead agent from this series directly
mediates oxidative DNA damage in the presence of cop-
per(II) using a ‘self-activating’ mechanism. There is good
agreement between the in vitro and cellular DNA damaging
modes supporting a mechanism closely related to copper
complexes of naturally occurring marine alkaloids along
with macrocyclic colibactin. Therefore, our work shows by
applying this particular synthetic strategy, it is possible to
simulate the activity of state-of-art DNA damaging natu-
ral products. This discovery now provides a framework for
future investigators to develop enhanced DNA damaging
agents with unique chemotherapeutic properties that may
circumvent innate cellular DNA repair machinery.
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